MRNY: YIELDMAX(R) MRNA OPTION INCOME STRATEGY ETF
Share-split context: A reverse split was recorded on Dec 1, 2025 with coefficient 0.1. A reverse split combines multiple old shares into fewer new shares and mechanically raises the quoted price per share. That mechanical increase does not restore lost investment value. The returns in this report are already split-adjusted, while reverse-split history remains a separate structural warning.
What this ETF is trying to do
The YIELDMAX(R) MRNA OPTION INCOME STRATEGY ETF (ticker: MRNY) is an exchange-traded fund that uses an option income strategy. This means it uses specific financial tools called options to try and generate income for investors. Based on its top holdings, the fund focuses heavily on MRNA options.
What the numbers show
It is important to understand that "price return" and "total return" are two different things. Price return only tracks how much the share price moves. Total return includes both the price movement and the cash distributions paid out to investors.
For MRNY, the numbers show significant growth:
• Year-to-Date (YTD): The price return is approximately 173.47%, while the total return is approximately 422.32%.
• One-Year: The price return is approximately 119.67%, while the total return is approximately 437.01%.
This ETF has a history of reverse splits. In a reverse split, multiple old shares are combined into fewer new shares. This causes the price per share to rise mechanically, but it does not change the actual value of the investment.
Income and distribution explanation
This ETF is designed to provide frequent cash payments. The distribution yield is approximately 37.75%. This number describes the cash distributions relative to the current ETF price. Over the last 12 months, there were 53 distributions, which is a very frequent, weekly-like schedule. Most of these payments occurred on Thursdays.
While high yields can provide cash income, they do not guarantee that your original investment will stay the same value.
NAV erosion explanation
"NAV erosion" is a term used to describe when the Net Asset Value (the actual value of the fund's assets) declines. Some investors worry that high distributions might cause this. However, for MRNY, the erosion-risk score is 100, and the label states "No price erosion detected." The severity of this risk is rated as "good," and there is no severe erosion-risk flag present.
Pros
• High Total Returns: The supplied data shows very high total returns over the last year.
• Frequent Income: The fund provides very frequent cash distributions.
• Strong Erosion Score: The current measurements show no detected price erosion.
Cons
• High Yield Complexity: A very high distribution yield can sometimes be misleading; it is not the same as total return.
• Split History: The fund has undergone a reverse split in the past.
Beginner takeaway
When looking at MRNY, it is vital to distinguish between the share price and the total return. Because this fund pays out a lot of cash frequently, the total return (which includes those payments) is much higher than the price return alone. Always remember that a high distribution yield provides cash, but it is not a guarantee of how the overall investment will perform.
Top Holdings
Structured portfolio holdings supplied by the ETF data provider. These figures are not generated by the AI article.
| # | Holding | Ticker | Weight |
|---|---|---|---|
| 1 | MRNA US 07/17/26 C50 | n/a | 41.50% |
| 2 | MRNA 07/17/2026 50.01 C | n/a | 4.87% |
| 3 | FIRST AMERICAN GOVERNMENT OBLIGS X | FGXXX | 4.32% |
| 4 | MRNA US 07/02/26 C65 | n/a | 3.58% |
| 5 | MRNA US 07/02/26 C72 | n/a | 3.22% |
| 6 | MRNA US 07/10/26 C77 | n/a | 3.17% |
| 7 | CASH OFFSET | n/a | 3.12% |
| 8 | MRNA US 07/02/26 C66 | n/a | 2.96% |
| 9 | MRNA US 07/10/26 C79 | n/a | 1.42% |
| 10 | MRNA US 07/10/26 C78 | n/a | 1.13% |